Spinal Anesthesia - continued

By

Summary

Ever since the introduction of local anesthetics, physicians have investigated different methods of using them. Spinal anesthesia has enjoyed a long and successful history since the late nineteenth century and is currently more popular than ever. Mastery of spinal anesthesia comes with practice; diligence; and knowledge of physiology, pharmacology, and anatomy. Patient safety must always be at the forefront when considering performing a spinal anesthetic. The ease of performance and versatility of spinal anesthesia will continue to result in its widespread popularity in both hospital and ambulatory surgical applications.

REFERENCES:

1.

Koller C: Vorlaufige Mittheilung ¨uber locale Anasthesirung am Auge. Klin Mbl Augenheilk 1884;22:60–63.

2.

Halsted WS: Practical comments on the use and abuse of cocaine; suggested by its invariably successful employment in more than a thousand minor surgical operations. NY Med J 1885;42:294.

3.

Corning JL: Spinal anaesthesia and local medication of the cord. NY Med J 1885;42:483–485.

4.

Gorelick PB, Zych D: James Leonard Corning and the early history of spinal puncture. Neurology 1987;37:672–674.

5.

Wynter E: Four cases of tubercular meningitis inwhich paracentesis of the theca vertebralis was performed for relief of fluid pressure. Lancet 1891:981–982.

6.

Ball C, Westhorpe R: Local anaesthesia—Early spinal anaesthesia. Anaesth Intensive Care 2003;31:493.

7.

Bier A: Experiments regarding the cocainization of the spinal cord. Dtsch Z Chir 1899;51:361–369.

8.

Marx GF: The first spinal anesthesia.Who deserves the laurels? Reg Anesth 1994;19:429–430.

9.

Wulf HF: The centennial of spinal anesthesia. Anesthesiology 1998;89:500–506.

10.

Larson MD: Tait and Caglieri: The First Spinal Anesthetic in America. Anesthesiology 1996;85:913–919.

11.

Matas R: Local and regional anesthesiawith cocaine and other analgesic drugs, including the subarachnoid method, as applied in the general surgical practice. Phil Med J 1900;6:820–843.

12.

Vandam LD: On the origins of intrathecal anesthesia. Reg Anesth Pain Med 1998;23:335–339.

13.

Tuffier T: Anesthesie medullaire chirurgicale par injection sousarachnoidienne lombaire de cocaine; technique et resultats. Sem Med 1900;20:167.

14.

Barker AE: A report on clinical experiences with spinal analgesia in 100 cases and some reflections on the procedure. BMJ 1907;1:665– 674.

15.

Labat G: Circulatory disturbances associated with subarachnoid nerve block. Long Island Med J 1927;21:573.

16.

Pitkin G: Controllable spinal anesthesia. Am J Surg 1928;5:537.

17.

Sise LF: Spinal anesthesia for upper and lower abdominal operations. N Engl J Med 1928;199:61.

18.

Sise LF: Pontocainglucose for spinal anesthesia. Surg Clin North Am 1935;15:1501.

19.

Brown DL, Fink BR: The history of neural blockade and pain management. In Cousins MJ, Bridenbaugh PO (eds): Neural Blockade, 3rd ed. Lippincott-Raven, 1998, pp 3–27.

20.

Adriani J, Roman-Vega D: Saddle block anesthesia. Am J Surg 1946;71:12.

21.

Dripps RD, Vandam LD: Long-term follow-up of patients who received 10,098 spinal anesthetics: failure to discover major neurologic sequelae. JAMA 1954;156:1486–1491.

22.

Greene HM: Lumbar puncture and the prevention of postdural puncture headache. JAMA 1926;86:391–392.

23.

Greene BA:A26 gauge lumbar puncture needle: Its value in the prophylaxis of headache following spinal analgesia for vaginal delivery. Anesthesiology 1950;11:464–469.

24.

Hart JR, Whitacre RJ: Pencil-point needle in prevention of postspinal headache. JAMA 1951;147:657–658.

25.

SprotteG, Schedel R,Pajunk H, et:An“atraumatic” universal needle for single-shot regional anesthesia: Clinical results and a 6 year trial in over 30,000 regional anesthesias. Reg Anaesth 1987;10:104–108.

26.

Calthorpe N: The history of spinal needles: Getting to the point. Anaesthesia 2004;59:1231–1241.

27.

Bamford C, Sibley W, Laguna J: Anesthesia in multiple sclerosis. Can J Neurol Sci 1978;5:41–44.

28.

Kytta J, Rosenberg PH: Anaesthesia for patients with multiple sclerosis. Ann Chir Gynaecol 1984;73:299–303.

29.

Bouchard P, Caillet JB, Monnet F, et al: Spinal anesthesia and multiple sclerosis. Ann Fr Anesth Reanim 1984;3:194–198.

30.

Levesque P,Marsepoil T, Ho P, et al:Multiple sclerosis disclosed by spinal anesthesia. Ann Fr Anesth Reanim 1988;7: 68–70.

31.

Vadalouca A, Moka E, Sykiotis C: Combined spinal-epidural technique for total hysterectomy in a patientwith advanced, progressive multiple sclerosis. Reg Anesth Pain Med 2002;27:540–541.

32.

Thompson RC, Liberthson RR, Lowenstein E: Perioperative anesthetic risk of noncardiac surgery in hypertrophic obstructive cardiomyopathy. JAMA 1985;254:2419–2421.

33.

Loubser P, Suh K, Cohen S: Adverse effects of spinal anesthesia in a patient with idiopathic hypertrophic subaortic stenosis. Anesth Analg 1984;60:228–230.

34.

McDonald SB: Is neuraxial blockade contraindicated in the patient with aortic stenosis? Reg Anesth Pain Med 2004;29:496–502.

35.

O’Keefe JHJr, Shub C, Rettke SR: Risk of noncardiac surgical procedures in patients with aortic stenosis.Mayo Clin Proc 1989;64:400– 405.

36.

Collard CD, Eappen S, Lynch EP, et al: Continuous spinal anesthesia with invasive hemodynamic monitoring for surgical repair of the hip in two patients with severe aortic stenosis. Anesth Analg 1995;81:195–198.

37.

Reiman A, Anson B: Vertebral termination of the spinal cord with report of a case of sacral cord. Anat Rec 1944;88:127.

38.

Bromage PR: Neurological complications of subarachnoid and epidural anaesthesia. Acta Anaesthesiol Scand 1997;41:439–444.

39.

Covino B: Pharmacology of local anaesthetic agents. Br J Anaesth 1986;58:701–716.

40.

Greene NM: Uptake and elimination of local anesthetics during spinal anesthesia. Anesth Analg 1983;62:1013–1024.

41.

Stienstra R, Greene NM: Factors affecting the subarachnoid spread of local anesthetic solutions. Reg Anesth 1991;16:1–6.

42.

Cohen EN: Distribution of local anesthetic agents in the neuraxis of the dog. Anesthesiology 1968;29:1002–1005.

43.

Schell RM, Brauer FS, Cole DJ, et al: Persistent sacral nerve root deficits after continuous spinal anaesthesia. Can J Anaesth 1991;38:908–911.

44.

Hogan Q: Size of human lower thoracic and lumbosacral nerve roots. Anesthesiology 1996;85:37–42.

45.

Kaneko S, Matsumoto M, Tsuruta S, et al: The nerve root entry zone is highly vulnerable to intrathecal tetracaine in rabbits. Anesth Analg 2005;101:107–114.

46.

Takenami T, Yagishita S, Asato F, et al: Neurotoxicity of intrathecally administered tetracaine commences at the posterior roots near entry into the spinal cord. Reg Anesth Pain Med 2000;25:372– 379.

47.

Kristensen JD, Karlsten R, Gordh T: Spinal cord blood flow after intrathecal injection of ropivacaine and bupivacaine with or without epinephrine in rats. Acta Anaesthesiol Scand 1998;42:685–690.

48.

Dohi S, Matsumiya N, Takeshima R, et al: The effects of subarachnoid lidocaine and phenylephrine on spinal cord and cerebral blood flow in dogs. Anesthesiology 1984;61:238–244.

49.

Kozody R, Palahniuk RJ, Cumming MO: Spinal cord blood flow following subarachnoid tetracaine. Can Anaesth Soc J 1985;32:23–29.

50.

Greene NM: Distribution of local anesthetic solutions within the subarachnoid space. Anesth Analg 1985;64:715–730.

51.

Horlocker TT, Wedel DJ: Density, specific gravity, and baricity of spinal anesthetic solutions at body temperature. Anesth Analg 1993;76:1015–1018.

52.

Hallworth SP, Fernando R, ColumbMO, et al: The effect of posture and baricity on the spread of intrathecal bupivacaine for elective cesarean delivery. Anesth Analg 2005;100:1159–1165.

53.

McLeod GA: Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose. Br J Anaesth 2004;92:547–551.

54.

Brown DT, Wildsmith JA, Covino BG, et al: Effect of baricity on spinal anaesthesia with amethocaine. Br J Anaesth 1980;52:589–596.

55.

Siker ES, Wolfson B, Stewart WD, et al: Mepivacaine for spinal anesthesia: Effects of changes in concentration and baricity. Anesth Analg 1966;45:191–196.

56.

ChambersWA, Edstrom HH, Scott DB: Effect of baricity on spinal anaesthesia with bupivacaine. Br J Anaesth 1981;53:279–282.

57.

DensonDD, Bridenbaugh PO,Turner PA, et al:Comparison of neural blockade and pharmacokinetics after subarachnoid lidocaine in the rhesus monkey. II: Effects of volume, osmolality, and baricity. Anesth Analg 1983;62:995–1001.

58.

Hare GM, Ngan JC: Density determination of local anaesthetic opioid mixtures for spinal anaesthesia. Can J Anaesth 1998;45:341–346.

59.

BodilyMN,Carpenter RL,Owens BD: Lidocaine 0.5% spinal anaesthesia: A hypobaric solution for short-stay perirectal surgery. Can J Anaesth 1992;39:770–773.

60.

Lui AC, Polis TZ, Cicutti NJ: Densities of cerebrospinal fluid and spinal anaesthetic solutions in surgical patients at body temperature. Can J Anaesth 1998;45:297–303.

61.

Sheskey MC, Rocco AG, Bizzari-Schmid M, et al: A doseresponse study of bupivacaine for spinal anesthesia. Anesth Analg 1983;62:931–935.

62.

Hogan QH, Prost R, Kulier A, et al:Magnetic resonance imaging of cerebrospinal fluid volume and the influence of body habitus and abdominal pressure. Anesthesiology 1996;84: 1341–1349.

63.

Carpenter RL, Hogan QH, Liu SS, et al: Lumbosacral cerebrospinal fluid volume is the primary determinant of sensory block extent and duration during spinal anesthesia. Anesthesiology 1998;89: 24–29.

64.

Higuchi H, Hirata J, Adachi Y, et al: Influence of lumbosacral cerebrospinal fluid density, velocity, and volume on extent and duration of plain bupivacaine and spinal anesthesia. Anesthesiology 2004;100:106–114.

65.

Schneider M, Ettlin T, Kaufmann M, et al: Transient neurologic toxicity afterhyperbaric anesthesiawith5%lidocaine.AnesthAnalg 1993;76:1154–1157.

66.

Zaric D, Christiansen C, Pace NL, et al: Transient neurologic symptoms after spinal anesthesia with lidocaine versus other local anesthetics: Asystematic review of randomized, controlled trials.Anesth
Analg 2005;100:1811–1816.

67.

Zaric D, Christiansen C, Pace NL, et al: Transient neurologic symptoms(TNS)following spinal anaesthesiawith lidocaine versus other local anaesthetics. Cochrane Database Syst Rev 2005;100:1811–1816.

68.

Hampl KF, Schneider MC, UmmenhoferW, et al: Transient neurologic symptomsafter spinal anesthesia.AnesthAnalg 1995;81:1148–1153.

69.

Hampl KF, Heinzmann-Wiedmer S, Luginbuehl I, et al: Transient neurologic symptoms after spinal anesthesia: A lower incidence with prilocaine and bupivacaine than with lidocaine. Anesthesiology 1998;88:629–633.

70.

Keld DB, Hein L, Dalgaard M, et al: The incidence of transient neurologic symptoms (TNS) after spinal anaesthesia in patients undergoing surgery in the supine position. Hyperbaric lidocaine 5% versus hyperbaric bupivacaine 0.5%. Acta Anaesthesiol Scand 2000;44:285–290.

71.

Freedman JM, Li DK, Drasner K, et al: Transient neurologic symptoms after spinal anesthesia: an epidemiologic study of 1,863 patients. Anesthesiology 1998; 89: 633–41.

72.

Sumi M, Sakura S,Kosaka Y: Intrathecal hyperbaric 0.5% tetracaine as a possible cause of transient neurologic toxicity. Anesth Analg 1996; 82: 1076–7.

73.

Sakura S, Sumi M, Sakaguchi Y, et al: The addition of phenylephrine contributes to the development of transient neurologic symptoms after spinal anesthesia with 0.5% tetracaine. Anesthesiology 1997;87:771–778.

74.

Liguori GA, Zayas VM, Chisholm MF: Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. Anesthesiology 1998;88:619–623.

75.

Salazar F, Bogdanovich A, Adalia R, et al: Transient neurologic symptoms after spinal anaesthesia using isobaric 2% mepivacaine and isobaric 2% lidocaine. Acta Anaesthesiol Scand 2001;45:240–245.

76.

Eberhart LH, Morin AM, Kranke P, et al: Transient neurologic symptoms after spinal anesthesia. A quantitative systematic overview (meta-analysis) of randomized controlled studies. Anaesthesist 2002;51:539–546.

77.

Ganapathy S, Sandhu HB, Stockall CA, et al: Transient neurologic symptom(TNS) following intrathecal ropivacaine. Anesthesiology 2000;93:1537–1539.

78.

Buckenmaier CC 3rd, Nielsen KC, Pietrobon R, et al: Small-dose intrathecal lidocaine versus ropivacaine for anorectal surgery in an ambulatory setting. Anesth Analg 2002;95:1253–1257.

79.

BreebaartMB, VercauterenMP, Hoffmann VL, et al: Urinary bladder scanning after day-case arthroscopy under spinal anaesthesia: Comparison between lidocaine, ropivacaine, and levobupivacaine. Br J Anaesth 2003;90:309–313.

80.

Bridenbaugh PO,GreeneNM,Brull SJ: Spinal (subarachoid) neural blockade. In Cousins MJ, Bridenbaugh PO (eds): Neural Blockade, 3rd ed. Lippincott-Raven, 1998.

81.

Brown DL: Spinal, Epidural, and Caudal Anesthesia. In Miller RD (ed): Anesthesia, 4th ed. Churchill Livingston, 1994, pp 1505–1533.

82.

Pawlowski J, Sukhani R, Pappas AL, et al: The anesthetic and recovery profile of two doses (60 and 80 mg) of plain mepivacaine for ambulatory spinal anesthesia. Anesth Analg 2000;91:580–584.

83.

Kallio H, Snall EV, KeroMP, et al: A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10 mg. Anesth Analg 2004;99:713–717.

84.

McNamee DA, Parks L, McClelland AM, et al: Intrathecal ropivacaine for total hip arthroplasty: Double-blind comparative study with isobaric 7.5 mg/mL and 10 mg/mL solutions. Br J Anaesth 2001;87:743–747.

85.

Burke D, Kennedy S, Bannister J: Spinal anesthesia with 0.5% S(–)-bupivacaine for elective lower limb surgery. Reg Anesth Pain Med 1999;24:519–523.

86.

Glaser C, Marhofer P, Zimpfer G, et al: Levobupivacaine versus racemic bupivacaine for spinal anesthesia. Anesth Analg 2002;94:194–198.

87.

Alley EA, Kopacz DJ, McDonald SB, et al: Hyperbaric spinal levobupivacaine: A comparison to racemic bupivacaine in volunteers. Anesth Analg 2002;94:188–193.

88.

Smith KN, Kopacz DJ, McDonald SB: Spinal 2-chloroprocaine: A dose-ranging study and the effect of added epinephrine. Anesth Analg 2004;9:81–88.

89.

Tetzlaff JE, Dilger J, Yap E, et al: Cauda equina syndrome after spinal anaesthesia in a patient with severe vascular disease. Can J Anaesth 1998;45:667–669.

90.

Lee DS, Bui T, Ferrarese J, et al: Cauda equina syndrome after incidental total spinal anesthesia with 2% lidocaine. J Clin Anesth 1998;10:66–69

91.

Maehara Y, Kusunoki S, Kawamoto M, et al: A prospective multicenter trial to determine the incidence of transient neurologic symptomsafter spinal anesthesiawith phenylephrine added to 0.5% tetracaine. Hiroshima J Med Sci 2001;50:47–51.

92.

Kozody R, Palahniuk RJ,Wade JG, et al: The effect of subarachnoid epinephrine and phenylephrine on spinal cord blood flow. Can Anaesth Soc J 1984;31:503–508.

93.

Porter SS, Albin MS, Watson WA, et al: Spinal cord and cerebral blood flow responses to subarachnoid injection of local anesthetics with and without epinephrine. Acta Anaesthesiol Scand 1985;29:330–338.

94.

Concepcion M, Maddi R, Francis D, et al: Vasoconstrictors in spinal anesthesia with tetracaine—A comparison of epinephrineand phenylephrine. Anesth Analg 1984;63:134–138.

95.

Armstrong IR, Littlewood DG, Chambers WA: Spinal anesthesia with tetracaine—Effect of added vasoconstrictors. Anesth Analg 1983;62:793–795.

96.

Rice LJ,DeMars PD,Whalen TV, et al: Duration of spinal anesthesia in infants less than one year of age. Comparison of three hyperbaric techniques. Reg Anesth 1994;19:325–329.

97.

Chambers WA, Littlewood DG, Scott DB: Spinal anesthesia with hyperbaric bupivacaine: effect of added vasoconstrictors. Anesth Analg 1982;61:49–52.

98.

Moore JM, Liu SS, Pollock JE, et al: The effect of epinephrine on small-dose hyperbaric bupivacaine spinal anesthesia: Clinical implications for ambulatory surgery. Anesth Analg 1998;86:973–977.

99.

Racle JP, Poy JY, Benkhadra A, et al: Prolongation of spinal anesthesia with hyperbaric bupivacaine by adrenaline and clonidine in the elderly. Ann Fr Anesth Reanim 1988;7:139–144.

100.

Vercauteren MP, Jacobs S, Jacquemyn Y, et al: Intrathecal labor analgesia with bupivacaine and sufentanil: the effect of adding 2.25 micrograms of epinephrine. Reg Anesth Pain Med 2001;26:473–477.

101.

Goodman SR, Kim-Lo SH, Ciliberto CF, et al: Epinephrine is not a useful addition to intrathecal fentanyl or fentanyl-bupivacaine for labor analgesia. Reg Anesth Pain Med 2002;27:374–379.

102.

Gautier PE, Debry F, Fanard L, et al: Ambulatory combined spinal-epidural analgesia for labor. Influence of epinephrine on bupivacaine-sufentanil combination. Reg Anesth 1997;22:143–149.

103.

Chambers WA, Littlewood DG, Logan MR, et al: Effect of added epinephrine on spinal anesthesia with lidocaine. Anesth Analg 1981;60:417–420.

104.

Chiu AA, Liu S, Carpenter RL, et al: The effects of epinephrine on lidocaine spinal anesthesia: A cross-over study. Anesth Analg 1995;80:735–739.

105.

Racle JP, Benkhadra A, Poy JY: Subarachnoid anaesthesia produced by hyperbaric lignocaine in elderly patients. Prolongation of effect with adrenaline. Br J Anaesth 1988;60:831–835.

106.

Spivey DL: Epinephrine does not prolong lidocaine spinal anesthesia in term parturients. Anesth Analg 1985;64:468–470.

107.

Moore DC, Chadwick HS, Ready LB: Epinephrine prolongs lidocaine spinal: Pain in the operative site the most accurate method of determining local anesthetic duration. Anesthesiology 1987;67:416–418.

108.

Glynn CJ,Mather LE, Cousins MJ, et al: Spinal narcotics and respiratory depression. Lancet 1979;2:356–357.

109.

Cunningham AJ, McKenna JA, Skene DS: Single injection spinal anaesthesia with amethocaine and morphine for transurethral prostatectomy. Br J Anaesth 198355;:423–427.

110.

Nordberg G,Hedner T,Mellstrand T, et al: Pharmacokinetic aspects of intrathecal morphine analgesia. Anesthesiology 1984;60:448–454.

111.

Abouleish E, Rawal N, Rashad MN: The addition of 0.2 mg subarachnoid morphine to hyperbaric bupivacaine for cesarean delivery: A prospective study of 856 cases. Reg Anesth 1991;16:137–140.

112.

Borgeat A, Singer T: Nausea and vomiting after spinal anaesthesia with morphine. Acta Anaesthesiol Scand 1998;42:1231.

113.

Bonnet F, BuissonVB, Francois Y, et al: Effects of oral and subarachnoid clonidine on spinal anesthesia with bupivacaine. Reg Anesth 1990;15:211–214.

114.

Dobrydnjov I, Axelsson K, Thorn SE, et al: Clonidine combined with small-dose bupivacaine during spinal anesthesia for inguinal herniorrhaphy: A randomized double-blinded study. Anesth Analg 2003;96:1496–503.

115.

Strebel S, Gurzeler JA, Schneider MC, et al: Small-dose intrathecal clonidine and isobaric bupivacaine for orthopedic surgery: A doseresponse study. Anesth Analg 2004;99:1231–1238.

116.

Filos KS, Goudas LC, Patroni O, et al: Hemodynamic and analgesic profile after intrathecal clonidine in humans:Adose response study. Anesthesiology 1994;81:591–601.

117.

Hassenbusch SJ, Gunes S,Wachsman S, et al: Intrathecal clonidine in the treatment of intractable pain: A phase I/II study. Pain Med 2002;3:85–91.

118.

Ackerman LL, Follett KA, Rosenquist RW: Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations. J Pain Symptom Manage 2003;26:668–77.

119.

Chen SR, Khan GM, Pan HL: Antiallodynic effect of intrathecal neostigmine is mediated by spinal nitric oxide in a rat model of diabetic neuropathy. Anesthesiology 2001;95:1007–1012.

120.

Ho KM, Ismail H, LeeKC, et al:Use of intrathecal neostigmine as an adjunct to other spinal medications in perioperative and peripartum analgesia:Ameta-analysis.Anaesth Intensive Care 2005;33:41–53.

121.

Yegin A, Yilmaz M, Karsli B, et al: Analgesic effects of intrathecal neostigmine in perianal surgery. Eur J Anaesthesiol 2003;20:404–408.

122.

Tan P-H, Kuo J-H, Liu K, et al: Efficacy of intrathecal neostigmine for the relief of postinguinal hemiorrhaphy pain. Acta Anaesthesiol Scand 2000;44:1056–1060.

123.

Nakayama M, Kanaya N, Fujita S, et al: Effects of ephedrine on indocyanine green clearance during spinal anesthesia: Evaluation by the finger piece method. Anesth Analg 1993;77:947–949.

124.

Zinn SE, Fairley HB, Glenn JD: Liver function in patients with mild alcoholic hepatitis, after enflurane, nitrous oxide-narcotic, and spinal anesthesia. Anesth Analg 1985;64:487–490.

125.

IgarashiM,Kawana S, Iwasaki H, et al:Anesthetic management for a patientwith citrullinemia and liver cirrhosis.Masui 1995;44:96–99.

126.

Fukuda T, Okutani R, Kono K, et al: Anesthetic management for cesarean section of a patient with transient diabetes insipidus and acute severe liver dysfunction. Masui 1993;42:1511–1516.

127.

McNeillMJ, Bennet A: Use of regional anaesthesia in a patient with acute porphyria. Br J Anaesth 1990;64:371–373.

128.

Consolo D, Ouardirhi Y, Wessels C, et al: Obstetrical anaesthesia and porphyrias. Ann Fr Anesth Reanim 2005;24:428–431.

129.

Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition.III: Effects of general and spinal anaesthesia on regional blood flow and oxygen tensions. Br J Anaesth 1984;56:1247–1258.

130.

Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. IV: The effects of general and spinal anaesthesia on blood flow and cefoxitin disposition. Br J Anaesth 1985;57:1239–1247.

131.

Runciman WB, Mather LE, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. VI: Effects of general or subarachnoid anaesthesia on blood flow and chlormethiazole disposition. Br J Anaesth 1986; 58: 1308–1316.

132.

Mather LE, RuncimanWB, Ilsley AH, et al: A sheep preparation for studying interactions between blood flow and drug disposition. V: The effects of general and subarachnoid anaesthesia on blood flow and pethidine disposition. Br J Anaesth 1986;58:888–896.

133.

Bigler D, Hjortso NC, Edstrom H, et al: Comparative effects of intrathecal bupivacaine and tetracaine on analgesia, cardiovascular function and plasma catecholamines. Acta Anaesthesiol Scand 1986;30:199–203.

134.

Carpenter RL, Caplan RA, Brown DL, et al: Incidence and risk factors for side effects of spinal anesthesia. Anesthesiology 1992;76:906–916.

135.

Tarkkila P, Isola J: A regression model for identifying patients at high risk of hypotension, bradycardia and nausea during spinal anesthesia. Acta Anaesthesiol Scand 1992;36:554–558.

136.

Klasen J, Junger A, Hartmann B, et al: Differing incidences of relevant hypotension with combined spinal-epidural anesthesia and spinal anesthesia. Anesth Analg 2003;96:1491–1495.

137.

Hartmann B, Junger A, Klasen J, et al: The incidence and risk factors for hypotension after spinal anesthesia induction: An analysis with automated data collection. Anesth Analg 2002;94:1521–1529.

138.

Nishiyama T, Komatsu K, Hanaoka K: Comparison of hemodynamic and anesthetic effects of hyperbaric bupivacaine and tetracaine in spinal anesthesia. J Anesth 2003;17:218–222.

139.

Rooke GA, Freund PR, Jacobson AF: Hemodynamic response and change in organ blood volume during spinal anesthesia in elderly men with cardiac disease. Anesth Analg 1997;85:99–105.

140.

Shimosato S, Etsten BE: The role of the venous system in cardiocirculatory dynamics during spinal and epidural anesthesia in man. Anesthesiology 1969;30:619–628.

141.

Anzai Y,NishikawaT:Heart rate responses to body tilt during spinal anesthesia. Anesth Analg 1991;73:385–390.

142.

Bergenwald L,FreyschussU,KaijserL, et al:Cardiovascular response to spinal anaesthesia in elderly men: Effects of head-up tilt and dihydroergotamine administration. Clin Physiol 1981;1:453–460.

143.

Caplan RA, Ward RJ, Posner K, et al: Unexpected cardiac arrest during spinal anesthesia: A closed claims analysis of predisposing factors. Anesthesiology 1988;68:5–11.

144.

Bernards CM, Hymas NJ: Progression of first degree heart block to high-grade second degree block during spinal anaesthesia. Can J Anaesth 1992;39:173–175.

145.

Graves CL,Underwood PS, Klein RL, et al: Intravenous fluid administration as therapy for hypotension secondary to spinal anesthesia. Anesth Analg 1968;47:548–556.

146.

Venn PJ, Simpson DA, Rubin AP, et al: Effect of fluid preloading on cardiovascular variables after spinal anaesthesia with glucose-free 0.75% bupivacaine. Br J Anaesth 1989;63:682–687.

147.

Coe AJ, Revanas B: Is crystalloid preloading useful in spinal anaesthesia in the elderly? Anaesthesia 1990;45:241–243.

148.

Butterworth JF 4th, PiccioneWJr, Berrizbeitia LD, et al: Augmentation of venous return by adrenergic agonists during spinal anesthesia. Anesth Analg 1986;65:612–616.

149.

Ward RJ, Kennedy WF, Bonica JJ, et al: Experimental evaluation of atropine and vasopressors for the treatment of hypotension of high subarachnoid anesthesia. Anesth Analg 1966;45:621–629.

150.

Sidi A, Pollak D, Floman Y, et al: Hypobaric spinal anesthesia in the operative management of orthopedic emergencies in geriatric patients. Isr J Med Sci 1984;20:589–592.

151.

Sinclair CJ, Scott DB, Edstrom HH: Effect of the Trendelenberg position on spinal anaesthesia with hyperbaric bupivacaine. Br J Anaesth 1982;54:497–500.

152.

Ou CH, Tsou MY, Ting CK, et al: Occurrence of the Bezold-Jarisch reflex during Cesarean section under spinal anesthesia–a case report. Acta Anaesthesiol Taiwan 2004;42:175–178.

153.

Mackey DC, Carpenter RL, Thompson GE, et al: Bradycardia and asystole during spinal anesthesia: A report of three cases without morbidity. Anesthesiology 1989;70:866–868.

154.

Campagna JA, Carter C: Clinical relevance of the Bezold–Jarisch reflex. Anesthesiology 2003;98:1250–1260.

155.

Lesser JB, Sanborn KV, Valskys R, et al: Severe bradycardia during spinal and epidural anesthesia recorded by an anesthesia information management system. Anesthesiology 2003;99:859–866.

156.

Kinsella SM, Tuckey JP: Perioperative bradycardia and asystole: Relationship to vasovagal syncope and the Bezold–Jarisch reflex. Br J Anaesth 2001;86:859–868.

157.

Greene NM, Brull SJ: Physiology of Spinal Anesthesia, 4th ed. Williams &Wilkins, 1981.

158.

Steinbrook RA, Concepcion M, Topulos GP: Ventilatory responses to hypercapnia during bupivacaine spinal anesthesia. Anesth Analg 1988;67:247–252.

159.

Schneider MC, HolzgreveW: 100 years ago: Oskar Kreis, a pioneer in spinal obstetric analgesia at the University Women’s Clinic of Basel. Anaesthesist 2001;50:525–528.

160.

Taivainen T, Tuominen M, Rosenberg PH: Influence of obesity on the spread of spinal analgesia after injection of plain 0.5% bupivacaine at the L3-4 or L4-5 interspace. Br J Anaesth 1990;64:542–546.

161.

Tuominen M, Taivainen T, Rosenberg PH: Spread of spinal anaesthesia with plain 0.5% bupivacaine: Influence of the vertebral interspace used for injection. Br J Anaesth 1989;62:358–361.

162.

Tuominen M, Kuulasmaa K, Taivainen T, et al: Individual predictability of repeated spinal anaesthesia with isobaric bupivacaine. Acta Anaesthesiol Scand 1989;33:13–14.

163.

Sundnes KO, Vaagenes P, Skretting P, et al: Spinal analgesia with hyperbaric bupivacaine: Effects of volume of solution. Br J Anaesth 1982;54:69–74.

164.

Konishi R,Mitsuhata H, Saitoh J, et al: The spread of subarachnoid hyperbaric dibucaine in the term parturient. Masui 1997;46:184–187.

165.

Veering BT, Ter Riet PM, Burm AG, et al: Spinal anaesthesia with 0.5% hyperbaric bupivacaine in elderly patients: Effect of site of injection on spread of analgesia. Br J Anaesth 1996;77:343–346.

166.

Cameron AE,Arnold RW, GhorisaMW, et al: Spinal analgesia using bupivacaine 0.5% plain. Variation in the extent of the block with patient age. Anaesthesia 1981;36:318–322.

167.

Pitkanen M, Haapaniemi L, Tuominen M, et al: Influence of age on spinal anaesthesia with isobaric 0.5% bupivacaine. Br J Anaesth 1984;56:279–284.

168.

Veering BT, BurmAG, Vletter AA, et al: The effect of age on systemic absorption and systemic disposition of bupivacaine after subarachnoid administration. Anesthesiology 1991;74:250–257.

169.

Racle JP, BenkhadraA, Poy JY, et al: Spinal analgesiawith hyperbaric bupivacaine: Influence of age. Br J Anaesth 1988;60:508–514.

170.

Schiffer E, Van Gessel E, Gamulin Z: Influence of sex on cerebrospinal fluid density in adults. Br J Anaesth 1999;83:943–944.

171.

ParggerH,HamplKF,AeschbachA, et al:Combinedeffectof patient variables on sensory level after spinal 0.5% plain bupivacaine. Acta Anaesthesiol Scand 1998;42:430–434.

172.

Povey HM, Jacobsen J, Westergaard-Nielsen J: Subarachnoid analgesia with hyperbaric 0.5% bupivacaine: Effect of a 60-min period of sitting. Acta Anaesthesiol Scand 1989;33:295–297.

173.

Alston RP, Littlewood DG, Meek R, et al: Spinal anesthesia with hyperbaric bupivacaine: Effects of concentration and volume when administered in the sitting position. Br J Anaesth 1988;61:144–148.

174.

Alston RP: Spinal anaesthesia with 0.5% bupivacaine 3 mL: Comparison of plain and hyperbaric solutions administered to seated patients. Br J Anaesth 1988;61:385–389.

175.

Mitchell RW, Bowler GM, Scott DB, et al: Effects of posture and baricity on spinal anaesthesia with 0.5% bupivacaine 5 ml. A double-blind study. Br J Anaesth 1988;61:139–143.

176.

PoveyHM,Olsen PA, Pihl H: Spinal analgesiawith hyperbaric 0.5% bupivacaine: effects of different patient positions.ActaAnaesthesiol Scand 1987;31:616–619.

<p style="font-size: 12p
Share on: Post on Facebook Facebook Add to your del.icio.us del.icio.us Digg this story Digg StumbleUpon StumbleUpon Twitter Twitter

Subscribe to comments feed Comments (0 posted)

total: | displaying:

Post your comment

  • Bold
  • Italic
  • Underline
  • Quote

Please enter the code you see in the image:

UPCOMING NYSORA EVENTS
US-Guided RA Boot Camps
Genk, Belgium
06/17/2016 (+ 2016 Dates)
BOUTIQUE WORKSHOPS
New York, NY
06/11/2024(+ 2016 Dates)
15th ANNUAL SYMPOSIUM
New York, NY
09/23/2016
P.o.C. Ultrasound for the Pediatric Anesthesiologist
Boston, MA
9/30/2016
Pediatric Anesthesia Update
Dubai, UAE
11/03/2024

Tagged as:

No tags for this article

Image gallery

Rate this article

0